Irish national real-world analysis of the clinical and economic impact of 21-gene oncotype DX® testing in early-stage, 1-3 lymph node-positive, oestrogen receptor-positive, HER2-negative, breast cancer
Browne, I M, McLaughlin, R A, Weadick, C S, O'Sullivan, S, McSorley, L M, Hadi, D K, Millen, S J, Higgins, M J, Crown, J P, Prichard, R S, McCartan, D P, Hill, A Dk, Connolly, R M, Noonan, S A, O'Mahony, D, Murray, C, O'Hanlon-Brown, C, Hennessy, B T, Quinn, C M, Kelly, C M, O'Reilly, S, Morris, P G, Walshe, J M
Published in Breast cancer research and treatment (04.10.2024)
Published in Breast cancer research and treatment (04.10.2024)
Get full text
Journal Article